COO
The Cooper Companies, Inc.
Ophthalmic Goods- 売上
- $4.1bn
- 時価総額
- $14.5bn
株価 $72.65 · 100株 7,265円
| 期 | 23/10 | 24/10 | 25/10 |
|---|---|---|---|
| 売上 | $3.6bn | $3.9bn | $4.1bn |
| 成長率 | — | 8.4% | 5.1% |
| 総利益 | $2.4bn | $2.6bn | $2.7bn |
| 総利益率 | 65.6% | 66.6% | 65.5% |
| 販管費 | $1.5bn | $1.5bn | $1.6bn |
| 販管費率 | 41.8% | 39.4% | 39.8% |
| 営利 | $533m | $706m | $683m |
| 営利率 | 14.8% | 18.1% | 16.7% |
| 純利益 | $294m | $392m | $375m |
| PBR | 1.9 | 1.8 | 1.8 |
| PSR | 4.0 | 3.7 | 3.5 |
| PGPR | 6.1 | 5.6 | 5.4 |
| PER | 49 | 37 | 39 |
| ﾈｯﾄｷｬｯｼｭ | ▲$2.4bn | ▲$2.4bn | ▲$2.3bn |
| EV/EBITDA | 18.8 | 15.7 | 15.9 |
| Rule of 40 | — | 27% | 22% |
| セールス効率 | — | 732% | 92% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）